{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:32:10Z","timestamp":1779237130584,"version":"3.51.4"},"reference-count":89,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1669,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1755-3768.2010.02079.x","type":"journal-article","created":{"date-parts":[[2011,2,5]],"date-time":"2011-02-05T09:15:36Z","timestamp":1296897336000},"page":"405-411","source":"Crossref","is-referenced-by-count":88,"title":["Treatment of proliferative diabetic retinopathy with anti-VEGF agents"],"prefix":"10.1111","volume":"89","author":[{"given":"Aysha","family":"Salam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raeba","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,2,5]]},"reference":[{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/IIO.0b013e31819fd84a","article-title":"Anti-VEGF therapy in proliferative diabetic retinopathy","volume":"49","author":"Abdallah","year":"2009","journal-title":"Int Ophthalmol Clin"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","article-title":"Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy","volume":"118","author":"Adamis","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ophtha.2005.10.012","article-title":"Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals","volume":"113","author":"Adamis","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.ophtha.2009.07.001","article-title":"Intravitreal IVB for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial","volume":"116","author":"Ahmadieh","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/157339909787314121","article-title":"Intravitreal IVB for diabetic retinopathy","volume":"5","author":"Arevalo","year":"2009","journal-title":"Curr Diabetes Rev"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bjo.2007.127142","article-title":"Tractional retinal detachment following intravitreal IVB (Avastin) in patients with severe proliferative diabetic retinopathy","volume":"92","author":"Arevalo","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.eye.6702980","article-title":"Intravitreal IVB (Avastin) for proliferative diabetic retinopathy: 6-months follow-up","volume":"23","author":"Arevalo","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB98|cit8","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ophtha.2008.12.024","article-title":"Vitreous mediators after intravitreal IVB or triamcinolone acetonide in eyes with proliferative diabetic retinopathy","volume":"116","author":"Arimura","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006982-200603000-00016","article-title":"Regression of retinal and iris neovascularization after intravitreal IVB (Avastin) treatment","volume":"26","author":"Avery","year":"2006","journal-title":"Retina"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1695 e1","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal IVB (Avastin) in the treatment of proliferative diabetic retinopathy","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB101|cit11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ajo.2006.11.047","article-title":"Retinal pigment epithelial tear after intravitreal ranibizumab","volume":"143","author":"Bakri","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB102|cit12","first-page":"1542","article-title":"The relation between IVB injection and the formation of subretinal fibrosis in diabetic patients with panretinal photocoagulation","volume":"41\/2","author":"Batman","year":"2010","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB103|cit13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1755-3768.2008.01355.x","article-title":"Bevacizumab as adjuvant for neovascular glaucoma","volume":"88","author":"Beutel","year":"2010","journal-title":"Acta Opthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archophthalmol.2008.565","article-title":"Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. Diabetic Retinopathy Clinical Research Network","volume":"127","author":"Brucker","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/112067210801800214","article-title":"Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma","volume":"18","author":"Chalam","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/01.iae.0000225351.87205.69","article-title":"Use of intravitreal IVB as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy","volume":"26","author":"Chen","year":"2006","journal-title":"Retina"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB107|cit17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/IAE.0b013e31819a5fc2","article-title":"Panretinal photocoagulation combined with intravitreal IVB in high-risk proliferative diabetic retinopathy","volume":"29","author":"Cho","year":"2009","journal-title":"Retina"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2125.2008.03278.x","article-title":"Intravitreal IVB (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-up","volume":"66","author":"Costagliola","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB109|cit19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00417-010-1303-3","article-title":"Intravitreal IVB for surgical treatment of severe proliferative diabetic retinopathy","volume":"248","author":"De Ruggiero","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3129\/i09-108","article-title":"Intravitreal IVB and aqueous shunting surgery for neovascular glaucoma: safety and efficacy","volume":"44","author":"Eid","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB21|cit21","first-page":"149","article-title":"Intravitreal IVB treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy","volume":"1","author":"El-Batarny","year":"2007","journal-title":"Clin Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB112|cit22","first-page":"1539","article-title":"The results of intravitreal IVB injections for persistent neovascularizations in proliferative diabetic retinopathy after photocoagulation therapy","volume":"30\/4","author":"Erdol","year":"2010","journal-title":"Retina"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB113|cit23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/eye.2009.94","article-title":"Therapeutic effect of IVB injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy","volume":"24\/4","author":"Falavarjani","year":"2010","journal-title":"Eye"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0161-6420(92)31779-8","article-title":"Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group","volume":"99","author":"Flynn","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB115|cit25","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1167\/iovs.09-4065","article-title":"Alterations in the intraocular cytokine milieu after intravitreal bevacizumab","volume":"51","author":"Forooghian","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajo.2007.01.052","article-title":"Intraocular pressure effects of pegaptanib (Macugen) injections in patients with and without glaucoma","volume":"143","author":"Frenkel","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/archopht.124.9.1365","article-title":"Vanishing disc neovascularization following intravitreal IVB (avastin) injection","volume":"124","author":"Friedlander","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB118|cit28","first-page":"52","article-title":"Intravitreal IVB and panretinal photocoagulation as combined treatment in proliferative diabetic retinopathy","volume":"18\/1","author":"Fulda","year":"2010","journal-title":"Retina-Vitreus"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/eye.2008.99","article-title":"IVB (Avastin) as a surgical adjunct in diabetic vitrectomy for fibrovascular disease","volume":"23","author":"Gandhi","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB31|cit31","first-page":"583","article-title":"Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group","volume":"88","author":"Group TDRSR","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB122|cit32","first-page":"122","article-title":"The anatomical and functional outcomes and intraoperative complications of 20 gauge vs 23 gauge pars plana vitrectomy combined with phacoemulsification following intravitreal IVB in diabetic tractional retinal detachment","volume":"18\/2","author":"Gungel","year":"2010","journal-title":"Retina-Vitreus"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB123|cit33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/IAE.0b013e3181c70168","article-title":"Dose of intravitreal IVB (Avastin) used as preoperative adjunct therapy for proliferative diabetic retinopathy","volume":"30","author":"Hattori","year":"2010","journal-title":"Retina"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB124|cit34","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/eye.2010.14","article-title":"Use of pegaptanib for recurrent and non-clearing vitreous haemorrhage in proliferative diabetic retinopathy","volume":"24","author":"Hornan","year":"2010","journal-title":"Eye"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/IAE.0b013e3181b094b7","article-title":"Intravitreal IVB and panretinal photocoagulation for proliferative diabetic retinopathy associated with vitreous hemorrhage","volume":"29","author":"Huang","year":"2009","journal-title":"Retina"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4103\/0301-4738.36480","article-title":"The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice","volume":"55","author":"Hussain","year":"2007","journal-title":"Indian J Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1442-9071.2006.01378.x","article-title":"Rapid resolution of severe disc new vessels in proliferative diabetic retinopathy following a single intravitreal injection of IVB (Avastin)","volume":"34","author":"Isaacs","year":"2006","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.eye.6702983","article-title":"Preferable use of intravitreal IVB as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy","volume":"23","author":"Ishikawa","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/sj.eye.6702575","article-title":"Inadvertent injection of triamcinolone into the crystalline lens","volume":"21","author":"Jalil","year":"2007a","journal-title":"Eye"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/sj.eye.6703018","article-title":"Intravitreal IVB (Avastin) causing acute glaucoma: an unreported complication","volume":"21","author":"Jalil","year":"2007b","journal-title":"Eye"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/08820530902800330","article-title":"Review of anti-VEGF therapy in proliferative diabetic retinopathy","volume":"84","author":"Jardeleza","year":"2009","journal-title":"Semin Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1600-0420.2007.01107.x","article-title":"Intravitreal bevacizumab for vitreous haemorrhage","volume":"86","author":"Jonas","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1755-3768.2008.01225.x","article-title":"Progression of tractional retinal detachment following intravitreal bevacizumab","volume":"87","author":"Jonas","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB134|cit44","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/01.iae.0000246884.76018.63","article-title":"Intravitreal IVB (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study)","volume":"26","author":"Jorge","year":"2006","journal-title":"Retina"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archopht.122.4.552","article-title":"The prevalence of diabetic retinopathy among adults in the United States","volume":"122","author":"Kempen","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB136|cit46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ajo.2010.03.016","article-title":"Histopathology of neovascular tissue from eyes with proliferative diabetic retinopathy after intravitreal IVB injection","volume":"150","author":"Kohno","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/eye.2008.179","article-title":"Intravitreal pegaptanib in severe proliferative diabetic retinopathy leading to the progression of tractional retinal detachment","volume":"23","author":"Krishnan","year":"2009","journal-title":"Eye"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1001\/archopht.124.6.920","article-title":"Pegaptanib as an adjunctive treatment for complicated neovascular diabetic retinopathy","volume":"124","author":"Krzystolik","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB139|cit49","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/IAE.0b013e3181bd2d7b","article-title":"Histology of fibrovascular membranes of proliferative diabetic retinopathy after intravitreal injection of bevacizumab","volume":"30\/3","author":"Kubota","year":"2010","journal-title":"Retina"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"e2675","DOI":"10.1371\/journal.pone.0002675","article-title":"The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy","volume":"3","author":"Kuiper","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1111\/j.1755-3768.2009.01575.x","article-title":"Efficacy and safety of one intravitreal injection of IVB in diabetic macular oedema","volume":"88","author":"Kumar","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/IAE.0b013e31819a5f98","article-title":"Safety of repeat intravitreal injections of IVB versus ranibizumab: our experience after 2,000 injections","volume":"29","author":"Ladas","year":"2009","journal-title":"Retina"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1600-0420.2007.01111.x","article-title":"Multiple retinal haemorrhages in diabetic retinopathy after adjunctive intravitreal IVB (Avastin) with pars plana vitrectomy","volume":"86","author":"Lee","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/jop.2008.0092","article-title":"Enlargement of the foveal avascular zone in diabetic retinopathy after adjunctive intravitreal IVB (avastin) with pars plana vitrectomy","volume":"25","author":"Lee","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"18902","DOI":"10.1073\/pnas.0509069102","article-title":"A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165","volume":"102","author":"Lee","year":"2006","journal-title":"PNAS"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3341\/kjo.2009.23.3.188","article-title":"Concentration of vascular endothelial growth factor after intracameral IVB injection in eyes with neovascular glaucoma","volume":"23","author":"Lim","year":"2009","journal-title":"Korean J Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB147|cit57","first-page":"1542","article-title":"Ghost cell glaucoma after intravitreal IVB for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy","volume":"41\/1","author":"Liu","year":"2010","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB148|cit58","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/IAE.0b013e3181a8eb88","article-title":"Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with IVB (avastin)","volume":"29","author":"Lo","year":"2009","journal-title":"Retina"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB149|cit59","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bjo.2008.151233","article-title":"Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal IVB (IBeTra study)","volume":"93","author":"Lucena","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB150|cit60","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/IAE.0b013e31818356fb","article-title":"Intravitreal IVB (Avastin) prevention of panretinal photocoagulation induced complications in patients with severe proliferative diabetic retinopathy","volume":"28","author":"Mason","year":"2008","journal-title":"Retina"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB151|cit61","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10384-008-0645-4","article-title":"Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab","volume":"53","author":"Matsuyama","year":"2009","journal-title":"Jpn J Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB63|cit62","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1755-3768.2008.01391.x","article-title":"Rapid and persistent regression of severe new vessels on the disc in proliferative diabetic retinopathy after a single intravitreal injection of pegaptanib","volume":"87","author":"Mendrinos","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB64|cit63","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1600-0420.2007.01042.x","article-title":"Intravitreal IVB (Avastin) in proliferative diabetic retinopathy","volume":"86","author":"Minnella","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB65|cit64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/112067210801800215","article-title":"Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial","volume":"18","author":"Mirshahi","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB66|cit65","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/bjo.2008.139378","article-title":"Retinal detachment with macular hole following intravitreal IVB in patient with severe proliferative diabetic retinopathy","volume":"92","author":"Mitamura","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB156|cit66","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/112067210901900526","article-title":"Intravitreal injection of IVB before vitrectomy for proliferative diabetic retinopathy","volume":"19","author":"Modarres","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB68|cit67","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00417-008-0914-4","article-title":"Intravitreal IVB in active progressive proliferative diabetic retinopathy","volume":"246","author":"Moradian","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB69|cit68","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.ophtha.2007.05.057","article-title":"IVB and retinal ischemia","volume":"114","author":"Neubauer","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB70|cit69","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.yexcr.2005.11.008","article-title":"VEGF function in vascular pathogenesis","volume":"312","author":"Ng","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB71|cit70","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ophtha.2008.11.005","article-title":"Microincision vitrectomy surgery and intravitreal IVB as a surgical adjunct to treat diabetic traction retinal detachment","volume":"116","author":"Oshima","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB161|cit71","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/IAE.0b013e3181cb463a","article-title":"Fibrous membranes in diabetic retinopathy and bevacizumab","volume":"30","author":"Pattwell","year":"2010","journal-title":"Retina"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB73|cit72","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00417-008-0774-y","article-title":"Injection of intravitreal IVB (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR)","volume":"246","author":"Rizzo","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB163|cit73","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/eye.2008.354","article-title":"Can a preoperative IVB injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage?","volume":"23","author":"Romano","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB75|cit74","first-page":"361","article-title":"Ranibizumab: phase III clinical trial results","volume":"19","author":"Rosenfeld","year":"2006","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB76|cit75","doi-asserted-by":"crossref","first-page":"1226 e1","DOI":"10.1016\/j.ophtha.2009.02.011","article-title":"Systemic adverse events after bevacizumab","volume":"116","author":"Roth","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB77|cit76","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00417-008-0874-8","article-title":"Vascular endothelial growth factor in fellow eyes of eyes injected with intravitreal bevacizumab","volume":"246","author":"Sawada","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB78|cit77","article-title":"Repeated intravitreal IVB (Avastin(R)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation","author":"Schmidinger","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB168|cit78","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00417-008-0902-8","article-title":"Intravitreal injection of IVB and gas for diabetic premacular hemorrhage with active fibrovascular proliferation","volume":"246","author":"Shih","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB80|cit79","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-0420.2007.01067.x","article-title":"Complications in patients after intravitreal injection of bevacizumab","volume":"86","author":"Shima","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB170|cit80","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3341\/kjo.2009.23.4.266","article-title":"Effects of an intravitreal IVB injection combined with panretinal photocoagulation on high-risk proliferative diabetic retinopathy","volume":"23","author":"Shin","year":"2009","journal-title":"Korean J Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB82|cit81","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00006982-200603000-00004","article-title":"Intravitreal IVB (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage","volume":"26","author":"Spaide","year":"2006","journal-title":"Retina"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB83|cit82","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1444-0938.2008.00295.x","article-title":"Rapid resolution of severe retinal neovascularisation in proliferative diabetic retinopathy following adjunctive intravitreal IVB (Avastin)","volume":"92","author":"Thew","year":"2009","journal-title":"Clin Exp Optom"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB84|cit83","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1600-0420.2007.01056.x","article-title":"Panretinal photocoagulation versus PRP plus intravitreal IVB for high-risk proliferative diabetic retinopathy (IBeHi study)","volume":"86","author":"Tonello","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB85|cit84","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/ICB.0b013e3181578dd8","article-title":"Tractional Retinal Detachment after Intravitreal injection of IVB in Proliferative Diabetic Retinopathy","volume":"3","author":"Torres-Soriano","year":"2009","journal-title":"Retin Cases Brief Rep"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB86|cit85","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.eye.6703036","article-title":"Progression of diabetic tractional retinal detachment following single injection of intravitreal Avastin","volume":"22","author":"Tranos","year":"2008","journal-title":"Eye"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB87|cit86","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00417-007-0660-z","article-title":"Twelve-month safety of intravitreal injections of IVB (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES)","volume":"246","author":"Wu","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB88|cit87","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ajo.2008.04.028","article-title":"IVB pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy","volume":"146","author":"Yang","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB89|cit88","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/IAE.0b013e3181a3b7ef","article-title":"IVB pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy","volume":"29","author":"Yeh","year":"2009","journal-title":"Retina"},{"key":"10.1111\/j.1755-3768.2010.02079.x-BIB90|cit89","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1442-9071.2008.01805.x","article-title":"Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series","volume":"36","author":"Yeoh","year":"2008","journal-title":"Clin Experiment Ophthalmol"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1755-3768.2010.02079.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1755-3768.2010.02079.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T21:46:46Z","timestamp":1712180806000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1755-3768.2010.02079.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,5]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1755-3768.2010.02079.x","relation":{},"ISSN":["1755-375X"],"issn-type":[{"value":"1755-375X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2,5]]}}}